Edwards Lifesciences Corporation
Edwards Lifesciences Corporation (EW) — Form 144: Proposed sale of shares
AI-generated summary
Officer Daniel J. Lippis proposed to sell 1,857 shares of Common stock with an aggregate market value of $193,592 through broker Charles Schwab & Co., Inc. The shares were acquired via an employee stock option exercise on November 10, 2026. The sale is associated with a trading plan adopted on February 13, 2026.
Key facts
- Seller
- Lippis Daniel J.
- Relationship
- Officer
- Shares to sell
- 1,857
- Market value
- $193,592.00
- Approximate sale date
- Nov 10, 2026
- Broker
- Charles Schwab & Co., Inc.
- Acquired
- Nov 10, 2026 · Employee Stock Option Exercise - See Remarks
Rule 10b5-1 plan · adopted Feb 13, 2026
Remarks
- The options on this filing may be sold over various dates.
More EW filings
- 4
Filed Nov 10, 2026
- 4
Filed Nov 9, 2026
- 4
Filed Nov 9, 2026
- 144
Filed Nov 9, 2026
- 144
Filed Nov 9, 2026
- 10-Q
Filed Nov 4, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.